Gilead Submits Filgotinib New Drug Application to US Food and Drug Administration Under Priority Review for Rheumatoid Arthritis Treatment | Small Molecules | News Channels - PipelineReview.com
What’s next for rheumatoid arthritis and cannabis? The GrowthOp One-and-a-half million people in the United States suffer from rheumatoid arthritis (RA). In fact, The Arthritis Foundation estimates that three times as many ...
Comments
Post a Comment